|
|
||||||||
Transplantation Biology Research Laboratory, Department of Cardiothoracic Surgery, University of Southern California School of Medicine, Los Angeles, CA 90033
Preformed and induced Ab responses present a major
immunological barrier to the use of pig organs for human
xenotransplantation. We generated IgM and IgG gene libraries
established from lymphocytes of patients treated with a bioartificial
liver (BAL) containing pig hepatocytes and used these libraries to
identify IgVH genes that encode human Ab responses to pig
xenoantigens. Genes encoded by the VH3 family are increased
in expression in patients following BAL treatment. cDNA libraries
representing the VH3 gene family were generated, and the
relative frequency of expression of genes used to encode the Ab
response was determined at days 0, 10, and 21. Ig genes derived from
the IGHV3-11 and IGHV3-74 germline progenitors increase in frequency
post-BAL. The IGHV3-11 gene encodes 12% of VH3 cDNA clones
expressed as IgM Abs at day 0 and 32.439.0% of cDNA clones encoding
IgM Abs in two patients at day 10. IGHV3-11 and IGHV3-74 genes encoding
IgM Abs in these patients are expressed without evidence of somatic
mutation. By day 21, an isotype switch occurs and IGHV3-11
IgVH progenitors encode IgG Abs that demonstrate somatic
mutation. We cloned these genes into a phagemid vector, expressed these
clones as single-chain Abs, and demonstrated that the IGHV3-11 gene
encodes Abs with the ability to bind to the gal
(1,3) gal epitope.
Our results demonstrate that the xenoantibody response in humans is
encoded by IgVH genes restricted to IGHV3-11 and IGHV3-74
germline progenitors. IgM Abs are expressed in germline configuration
and IgG Abs demonstrate somatic mutations by day
21.
This article has been cited by other articles:
![]() |
H. Xu, D. Yin, B. Naziruddin, L. Chen, A. Stark, Y. Wei, Y. Lei, J. Shen, J. S. Logan, G. W. Byrne, et al. The In Vitro and In Vivo Effects of Anti-Galactose Antibodies on Endothelial Cell Activation and Xenograft Rejection J. Immunol., February 1, 2003; 170(3): 1531 - 1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yin, L. Ma, A. Varghese, J. Shen, and A. S.-F. Chong Intact Active Bone Transplantation Synergizes with Anti-CD40 Ligand Therapy to Induce B Cell Tolerance J. Immunol., May 15, 2002; 168(10): 5352 - 5358. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |